“Adverse reactions to the vaccine, a study commission to evaluate them”

“Adverse reactions to the vaccine, a study commission to evaluate them”
Descriptive text here

The adverse reactions to the Covid vaccine they are a theme and also a certainty, according to many studies. A study commission to survey all the cases that have occurred, evaluate them and understand how to manage them is “appropriate”. “I believe it could be done peacefully by trying to understand the extent and type of adverse effects that occurred.” A commission that was supposed to coordinate with the commission of inquiry into the management of the pandemic, which is continuing. He said it the Minister of Health Orazio Schillaci to the Giornale d’Italia. “This year we recorded a very low number of people signing up for the vaccination campaign, including flu. So clarity would be useful” he explains.

Regarding a possible study commission, “I believe it would be appropriate to do it to have greater clarity and above all to give everyone greater peace of mind. We will work on it”, says the minister. As for the global Green Pass, “we have – continues Schillaci – no interest in applying it in Italy, I reiterated this recently. Obviously we want to protect the health of our fellow citizens, but without giving up our national priorities”. No virologist or “virostar”, promises the minister, head of the Covid inquiry commission for whose establishment the green light has recently arrived.

“We need to be ready if there are new diseases – continues the Minister of Health, responding on ‘Disease to the health priorities of Italians, I believe that we need to focus on screening, oncology, prevention. On many things that were neglected during Covid. We need to try to reduce the waiting lists, so there are many other priorities but if should there be a new Disease X, as it is evoked, we will be ready to face it in the best possible way.”

 
For Latest Updates Follow us on Google News
 

NEXT Viruses are more transmitted from humans to animals than vice versa